Perrigo (PRGO) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
Perrigo (PRGO) Rx Price Erosion Appears To Creep Above Guided Range - Goldman Sachs
May 31, 2017 5:12 AM EDTGoldman Sachs maintains Sell on Perrigo Co. (NYSE: PRGO) price target of $68.00.
Analyst Jami Rubin writes to clients in a late Tuesday note that RX prices have eroded 11-13 percent compared with company guidance of 9-11 percent for FY 2017.
"...we calculate... More
Perrigo (PRGO) Files Form 10-Q; Reports Q1 Results
May 30, 2017 5:17 PM EDTDelivered first quarter 2017 GAAP ("reported") net sales of $1.2 billion, led by consumer-facing businesses net sales of $958 millionRealized first quarter reported net income of $72 million and reported earnings per share ("EPS") of $0.50Achieved adjusted net income of $150 million and adjusted diluted EPS of $1.05First quarter cash flow from operations was $195 million; cash flow from operations of 272% as a percentage to net income and 130% as a percentage to adjusted net income CHCI profit improvement plan yielding positive results... More
